Leslie L Trigg - 01 Jun 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: Chair and CEO, Director
Signature: By: John L Brottem For: Leslie Trigg
Issuer symbol: OM
Transactions as of: 01 Jun 2022
Net transactions value: -$512,001
Form type: 4
Filing time: 02 Jun 2022, 16:30:44 UTC
Previous filing: 17 May 2022
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Options Exercise	$55,441	+14,289	+4.9%	$3.88	306,362	01 Jun 2022	Direct
transaction	OM	Common Stock	Sale	$299,307	-14,289	-4.7%	$20.95	292,073	01 Jun 2022	Direct	F1, F2
transaction	OM	Common Stock	Options Exercise	$60,959	+15,711	+5.4%	$3.88	307,784	01 Jun 2022	Direct
transaction	OM	Common Stock	Sale	$329,094	-15,711	-5.1%	$20.95	292,073	01 Jun 2022	Direct	F1, F2
holding	OM	Common Stock						8,770	01 Jun 2022	Trigg Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OM	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-15,711	-100%	$0.000000^*	0	01 Jun 2022	Common Stock	15,711	$3.88	Direct	F3
transaction	OM	Performance Options (right to buy)	Options Exercise	$0	-14,289	-7%	$0.000000	190,508	01 Jun 2022	Common Stock	14,289	$3.88	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022.
F2	The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 17,954 shares; $21.00-$22.99 - 11,446 shares; $23.00-$23.99 - 600 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	This option vested in 48 equal monthly installments beginning on October 19, 2017.
F4	In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.